Skip to main content
Erschienen in: Breast Cancer Research 1/2000

01.12.2001 | Paper Report

An in vitrobreast cell immortalisation assay

verfasst von: Jenny Gomm

Erschienen in: Breast Cancer Research | Ausgabe 1/2000

Einloggen, um Zugang zu erhalten

Excerpt

In most normal human cells there is a progressive shortening of chromosomal telomeres with successive cell divisions, leading ultimately to cell senescence. Cellular immortalisation is thought to occur by the reactivation of a telomerase which prevents telomere shortening and consequent growth arrest. As telomerase activity has been detected in 90% of cancers tested, it may be a good target in cancer treatment. Early-onset breast cancer is prevalent amongst patients with Li-Fraumeni syndrome (LFS). In previous studies, the authors demonstrated that normal breast epithelial cells from women with LFS immortalise spontaneously in culture. Normal breast epithelial cells were used in an in vitro assay to investigate the effects of chemopreventive and antitelomerase agents on telomerase activity and the immortalisation process. …
Literatur
1.
Zurück zum Zitat Herbert B-S, Wright AC, Passons CM, Wright WE, Ali IU, Kopelovich L, Shay JW: Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. J Natl Cancer Inst . 2001, 93: 39-45.CrossRefPubMed Herbert B-S, Wright AC, Passons CM, Wright WE, Ali IU, Kopelovich L, Shay JW: Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. J Natl Cancer Inst . 2001, 93: 39-45.CrossRefPubMed
Metadaten
Titel
An in vitrobreast cell immortalisation assay
verfasst von
Jenny Gomm
Publikationsdatum
01.12.2001
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 1/2000
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr-2001-68453

Weitere Artikel der Ausgabe 1/2000

Breast Cancer Research 1/2000 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.